Technegas named preferred lung imaging agent in new US guideline
Compartilhar
Cyclopharm (ASX:CYC) announced a major milestone for its flagship functional lung imaging product, Technegas, following the release of a draft US clinical guideline that recognises it as a preferred ventilation agent.
